Axsome Therapeutics(MX:AXSM)
MX$1,519.000.00 (0.00%)
MX:AXSM
Axsome Therapeutics earnings date
MX$1,519.00
At close:0.00 (0.00%)
Axsome Therapeutics (AXSM) Q1 2026 Earnings Report
1 Followers
MX:AXSM Q1 2026 EPS Results
- Actual EPS
- -MXN 23.38
- Consensus EPS
- -MXN 15.66
- Beat/Miss
- Missed by -MXN 7.72
- One Year Ago EPS
- -MXN 22.64
MX:AXSM Q1 2026 Revenue Results
- Actual Revenue
- MXN 3.55B
- Expected Revenue
- MXN 3.54B
- Beat/Miss
- Beat by +MXN 5.34M
- YoY Revenue Growth
- +57.42%
Earnings Announcement Details
- Quarter
- Q1 2026
- Date
- 05/04/2026
- Time
- Before Open
- Conference Call
- Monday, May 4, 2026
MX:AXSM Upcoming Earnings
Axsome Therapeutics's next earnings date is estimated for March 1, 2027, based on past reporting schedules.
Q1 2026 Earnings Call Audio
MX:AXSM Q1 2026 Earnings Call
0:00 / 0:00
Q1 2026 Earnings Slide Deck
Q1 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:AXSM Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 01, 2027 | 2026 (Q4) | -0.98- | -10.39 | ― | ― |
| Nov 02, 2026 | 2026 (Q3) | -11.76-4.64 | -17.44 | 73.40% (+12.80) | |
| Aug 10, 2026 | 2026 (Q2) | -16.55-18.37 | -18 | -2.06% (-0.37) | |
| May 04, 2026 | 2026 (Q1) | -15.66-23.38 | -22.64 | -3.28% (-0.74) | |
| Feb 23, 2026 | 2025 (Q4) | -12.88-10.39 | -28.58 | 63.64% (+18.19) | |
| Nov 03, 2025 | 2025 (Q3) | -15.98-17.44 | -24.87 | 29.85% (+7.42) | |
| Aug 04, 2025 | 2025 (Q2) | -19.58-18.00 | -30.99 | 41.92% (+12.99) | |
| May 05, 2025 | 2025 (Q1) | -25.07-22.64 | -26.72 | 15.28% (+4.08) | |
| Feb 18, 2025 | 2024 (Q4) | -18.58-28.58 | -38.6 | 25.96% (+10.02) | |
| Nov 12, 2024 | 2024 (Q3) | -25.66-24.87 | -24.49 | -1.52% (-0.37) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed


